ストックスクリーナーアプリを入手
26.44
1.07%
0.28
アフターアワーズ：
26.80
0.36
+1.36%
Adaptive Biotechnologies Corp (ADPT) 最新ニュース
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl
Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock - MarketBeat
Adaptive Biotechnologies Director Robert Hershberg Executes Stock Option and Sells Shares - Kalkine Media
Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) director exercises option at $6.32 strike - Stock Titan
Adaptive Biotechnologies director Neupert sells $3.1m in stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com India
Adaptive Biotechnologies director Neupert sells $3.1m in stock - Investing.com
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins Sells 278,676 Shares - MarketBeat
Adaptive Biotechnologies (ADPT) CEO sells 600K shares after exercising options - Stock Titan
Adaptive Biotechnologies (ADPT) director sells stock after option exercise - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) ex-officer plans new share sale - Stock Titan
Adaptive Biotechnologies stock hits 52-week high at 26.16 USD By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ:ADPT) Sets New 1-Year HighHere's What Happened - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 26.16 USD - Investing.com
66,000 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Handelsbanken Fonder AB - MarketBeat
Adaptive Biotechnologies (NASDAQ: ADPT) director plans to resell 30,664 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) insider plans more sales after $7.96M already sold - Stock Titan
Adaptive Biotechnologies (ADPT) ex-officer plans cashless option share sale - Stock Titan
Adaptive Biotech co-founder raises $15M for new startup to rethink how AI trains on science - GeekWire
Adaptive Biotechnologies (NASDAQ: ADPT) insider plans multimillion stock sale - Stock Titan
Adaptive Biotechnologies (ADPT) plans multi-million-dollar stock sale for 2026 - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) lines up six-figure share sale for 2026 - Stock Titan
Dimensional Fund Advisors LP Cuts Stock Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
576,266 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Wasatch Advisors LP - MarketBeat
Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales - simplywall.st
Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Susan Bobulsky Sells 3,000 Shares of Stock - MarketBeat
Adaptive Biotechnologies (ADPT) CCO Bobulsky sells 3,000 shares under plan - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Navigating the Growth Path with a 21.5% Revenue Surge - DirectorsTalk Interviews
Adaptive Biotechnologies (NASDAQ:ADPT) Sets New 12-Month HighHere's Why - MarketBeat
ADPT (ADPT) insider outlines Form 144 sale of 3,000 shares - stocktitan.net
Adaptive Biotechnologies stock hits 52-week high at 25.04 USD By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at 25.04 USD - Investing.com
Renaissance Technologies LLC Acquires Shares of 239,800 Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Corp (ADPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adaptive Biotechnologies Corp (ADPT) Stock News Today - TradingKey
Adaptive Biotechnologies Corp (1HM) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q4 2024 Earnings ReportResults, Call & Slides - tipranks.com
Adaptive Biotechnologies Corp (1HM) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (ADPT) Shares Fall 4.1% -- GF Value Says Still Overvalued - GuruFocus
Adaptive Biotechnologies Corp Q2 2026: Revenue $71.6M, EPS $(0.25) — 10-Q Summary - TradingView
Adaptive Biotechnologies (NASDAQ: ADPT) raises $345M in 2031 notes - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Navigating Growth in the Diagnostics Sector - DirectorsTalk Interviews
Adaptive Biotechnologies CCO Susan Bobulsky sells $31,176 shares By Investing.com - Investing.com South Africa
Form 4 Adaptive Biotechnologies Corp For: 3 August By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CCO Susan Bobulsky sells $31,176 shares - Investing.com
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $31,176.00 in Stock - MarketBeat
0.24%
1.51%
大文字化:
|
ボリューム (24 時間):